Provectus Biopharmaceuticals, Inc. (PVCT): Total Liabilities
$7.00M
As of 2025-12-31
$7.76M
As of 2026-06-30
-5.4%
3-year compound annual growth
-25.6%
5-year compound annual growth
+5.4%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.00M | +0.4% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $6.98M | -22.9% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $9.04M | +9.4% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $8.27M | +7.3% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $7.70M | -75.0% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $30.80M | +20.5% | 2022-03-29, Balance as of period end |
| 2019-12-31 | $25.55M | +31.7% | 2021-03-02, Balance as of period end |
| 2018-12-31 | $19.41M | +44.2% | 2020-03-05, Balance as of period end |
| 2017-12-31 | $13.46M | +528.2% | 2019-03-07, Balance as of period end |
| 2016-12-31 | $2.14M | -48.1% | 2018-03-23, Balance as of period end |
| 2015-12-31 | $4.12M | +314.7% | 2016-03-30, Balance as of period end |
| 2014-12-31 | $994.3K | -92.6% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $13.38M | +638.8% | 2015-03-12, Balance as of period end |
| 2012-12-31 | $1.81M | -45.6% | 2014-03-13, Balance as of period end |
| 2011-12-31 | $3.33M | -10.1% | 2013-03-14, Balance as of period end |
| 2010-12-31 | $3.70M | n/a | 2012-03-14, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $7.00M | +0.4% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.43M | -22.2% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $2.74M | -52.6% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $7.76M | +13.9% |
| Medicinova Inc (MNOV) | 2025-12-31 | $4.02M | +19.1% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $14.06M | -45.5% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $6.56M | +21.9% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $5.00M | -67.6% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $754.4K | +74.3% |
Compare PVCT, ALLR, HIND, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗